1. Companies
  2. Gufic Biosciences Share Price : GUFICBIO

Gufic Biosciences Share Price : GUFICBIO

Gufic Biosciences Limited is a significant player in the Indian pharmaceutical industry. The company is known for its high-quality pharmaceutical products. Gufic Biosciences share price reflects the trends and demands within the pharmaceutical sector.

Summary

  • Sector Healthcare
  • Industry Drug Manufacturers - Specialty & Generic
  • Phone 91 22 6726 1000
  • Website https://www.gufic.com

Major Holders Breakdown

  • 77.36% % of Shares Held by All Insider
  • 2.57% % of Shares Held by Institutions
  • 11.36% % of Float Held by Institutions
  • 8 Number of Institutions Holding Shares

Historical Chart

Try It Now
Adv banner 1
Stock Health and Score
64 Total Score
  • Fair Value : 553.48
  • Margin of Safety : 30%
  • Value Score :
    55
  • Growth Score :
    68
  • Quality Score :
    63
  • Technical Score :
    68
Support and Resistance
Short Term
3rd Resistance Point
485.51
2nd Resistance Point
463.94
1st Resistance Point
453.15
Last Settled Price
425.75
1st Support Level
420.79
2nd Support Level
399.21
3rd Support Level
377.64
Trade Orders Information
Order No. Entry Price Take Profit Invest % Exp. Payoff % Target Exp. Days
Currently buying is not recommended in this company.
Ad banner 2
Similar Stocks Expert Picks
Similar Stocks not found
Pivot Points
Time Period Pivot Distance Trend
Daily 424.45 -17.65 Bearish
Weekly 443.07 -36.27 Bearish
Monthly 452.90 -46.10 Bearish
Average True Range (ATR)
Time Period ATR Moved Remaining
Daily 21.57 22.70 -1.13
Weekly 43.53 39.50 4.03
Monthly 65.03 69.70 -4.67
Technical Snapshot (Daily)
Indicator Value Signal Remarks
STOCH 14 Over Sold
RSI 38 Neutral
BBAND 406.80 Over Sold
ATR 21.57 Volatility Up
MACD -1.88 Below Zero
SAR 486.39 Above Price
SMA20 460.64 Above Price
SMA50 443.06 Above Price
SMA100 429.24 Above Price
SMA200 387.99 Under Price
Inside Transactions
Insider Trading Relationship Date Transaction Cost #Shares Value ($)
Latest News
Sebi slaps Rs 10 lakh penalty on Axis Securities for violating stock brokers rules
Feb 22, 2025 12:07 PM
FIIs pull over Rs 1.12 lakh crore from Indian equities in 2025 so far amid 'Sell India, Buy China' trends
Feb 22, 2025 10:36 AM
Zomato, Jio Financial to bloat Nifty valuation, making it even pricier
Feb 22, 2025 10:12 AM
FII exodus: 5 sectors hit hardest by foreign fury in early February
Feb 22, 2025 09:15 AM
India Inc: Key takeaways from Q3 earnings season for investors
Feb 22, 2025 08:58 AM
Concurrent Gainers: Vedanta among 8 stocks on a 5-day winning streak
Feb 22, 2025 08:57 AM
Tesla India entry a limited threat to Mahindra as de-rating priced in after 17% drop in share price: CLSA
Feb 22, 2025 08:39 AM
Rethinking metrics for long-term investment success
Feb 22, 2025 07:49 AM
The rise of margin trading facility in India: A regulated product for smarter investing
Feb 22, 2025 07:07 AM
Who’s losing big? Zomato among top 10 stocks that FIIs trimmed in Q3
Feb 22, 2025 06:44 AM
Try It Now